ArticleAnnals of surgical oncology2024
Impact of
Article in Annals of surgical oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03208621 (Evaluation of PET and Laparoscopy in STagIng Advanced Gastric Cancer), which is not on this map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Evaluation of PET and Laparoscopy in STagIng Advanced Gastric Cancer: a Multicenter Prospective Study
Who cites it
5 citing papers in PubMed, 5 citations in OpenAlex.
- The Role of Diagnostic Laparoscopy in Staging and Treatment Planning of Gastric Cancer: A 400-Patient Retrospective Cohort Study.Diagnostics (Basel, Switzerland) · 2026Article
- Evolving Paradigms in Gastric Cancer Staging: From Conventional Imaging to Advanced MRI and Artificial Intelligence.Diagnostics (Basel, Switzerland) · 2026Review
- Article
- Staging accuracy in patients with clinical T2N0 gastric cancer: Implications for treatment sequencing.Surgery · 2025Article
- Construction of a predictive model for gastric cancer neuroaggression and clinical validation analysis: A single-center retrospective study.World journal of gastrointestinal surgery · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
41 authors at 20 institutions in 1 country.
Funding
Abstract
backgroundUnnecessary D2-gastrectomy and associated costs can be prevented after detecting non-curable gastric cancer, but impact of staging on treatment costs is unclear. This study determined the cost impact of MATERIALS AND
methodsIn this cost analysis, four staging strategies were modeled in a decision tree: (1)
results
conclusionsFor advanced gastric cancer, performing SL resulted in substantial cost savings by reducing unnecessary gastrectomies. In contrast, routine
trial registrationNCT03208621. This trial was registered prospectively on 30-06-2017.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.